http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0414254-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c5793331aa26c1bcd53672667e3f75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e82c16f73317c14a32bb0f1dd135745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca587a031f85bac1048543c7dd741311
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ce8de989cbe1b21d28ec683fc05a46
publicationDate 2021-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0414254-B1
titleOfInvention pharmaceutical composition comprising cinacalcet hcl
abstract pharmaceutical composition, and methods for making a pharmaceutical composition, for treating at least one disease and for controlling the rate of dissolution of a formulation the present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of an active receptor compound of calcium and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. the present invention further relates to a method for making the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition.
priorityDate 2003-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19226
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579344
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4329331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3839223
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6951305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426239840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86752264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19595567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426125353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566679
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XT35
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426033928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3680404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16019974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3769791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451024787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4432340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27IM2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174055
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GL67
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396436
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04089

Total number of triples: 78.